Evidence map›Paper›PMID 21666075›Full record

ArticleEukaryotic cell2011

Recombination can either help maintain very short telomeres or generate longer telomeres in yeast cells with weak telomerase activity.

Evelina Basenko, Zeki Topcu, Michael J McEachern

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Evelina BasenkoDepartment of Genetics, Fred Davison Life Science Complex, University of Georgia, Athens, GA 30602-7223, USA.
Zeki Topcu
Michael J McEachern
University of Georgia · US

Funding

RECOMBINATIONAL TELOMERE MAINTENANCER01GM061645 · NIGMS · UNIVERSITY OF GEORGIA (UGA) · PI MCEACHERN, MICHAEL J. · 2000 to 2010
$2.2M
NIGMS NIH HHS R01 GM061645NIGMS NIH HHS R01GM061645
6 · The paper itself

Abstract

Yeast mutants lacking telomerase are able to elongate their telomeres through processes involving homologous recombination. In this study, we investigated telomeric recombination in several mutants that normally maintain very short telomeres due to the presence of a partially functional telomerase. The abnormal colony morphology present in some mutants was correlated with especially short average telomere length and with a requirement for RAD52 for indefinite growth. Better-growing derivatives of some of the mutants were occasionally observed and were found to have substantially elongated telomeres. These telomeres were composed of alternating patterns of mutationally tagged telomeric repeats and wild-type repeats, an outcome consistent with amplification occurring via recombination rather than telomerase. Our results suggest that recombination at telomeres can produce two distinct outcomes in the mutants we studied. In occasional cells, recombination generates substantially longer telomeres, apparently through the roll-and-spread mechanism. However, in most cells, recombination appears limited to helping to maintain very short telomeres. The latter outcome likely represents a simplified form of recombinational telomere maintenance that is independent of the generation and copying of telomeric circles.

Indexed as

Recombination, GeneticFungal ProteinsGene Knockout TechniquesKluyveromycesRad52 DNA Repair and Recombination ProteinSequence DeletionTelomeraseTelomereFungal ProteinsRad52 DNA Repair and Recombination ProteinTelomerase

Identifiers

PMID21666075
PMCPMC3165439
OpenAlexW2097324917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.